A Brighton man has become the first patient at Sussex Eye Hospital to undergo a "pioneering" artificial cornea transplant.

Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

Pantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...

The global artificial cornea and corneal implant market size was US$ 381.5 million in 2021. The global artificial cornea and corneal implant market is forecast to grow to US$ 701.4 million by 2030 by ...

The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028. A corneal ...

Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals ...

The Association for Research in Vision and Ophthalmology (ARVO) Foundation has announced Maria Vittoria Cicinelli, MD, Denise ...

“Pantheon Vision has assembled a world-leading ophthalmic design team whose groundbreaking mindset has enabled the bold development of a revolutionary single-piece polymer artificial cornea for ...

A Brighton man has become the first patient at Sussex Eye Hospital to undergo a "pioneering" artificial cornea transplant. David Orams said he began suffering vision loss six years ago and despite ...